companydata.dkcompanydata.dk

Thermo Fisher Diagnostics ApS: Financial statements 2023

CVR: 27640745

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Thermo Fisher Diagnostics ApS (CVR 27640745) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 31,409,000 and a net result of DKK 6,600,000 compared with DKK 12,562,000 the year before. That is a decrease of 28.8% compared with the year before. Equity in the 2023 report amounted to DKK 63,055,000. The solvency ratio was 48.5%. The company had 31 employees in the financial year.

Gross Profit
DKK 31,409,000
Profit/Loss
DKK 6,600,000
Equity
DKK 63,055,000
Total Assets
DKK 130,040,000
Employees
31

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-31.4M6.6M63.1M31
2022-44.1M12.6M56.5M28
2021-33.1M1.2M43.9M31
2020-34.7M5M42.7M35
2019-35.9M7.5M37.7M31

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Simon Lie joins the board of Thermo Fisher Diagnostics ApSDec 22, 2023

As of December 22, 2023, Simon Lie has joined the board of directors of Thermo Fisher Diagnostics ApS.

Michael Toftvad leaves the board of Thermo Fisher Diagnostics ApSDec 22, 2023

As of December 22, 2023, Michael Toftvad has left the board of directors of Thermo Fisher Diagnostics ApS.

Thermo Fisher Diagnostics ApS: The 2022 annual report is outJul 3, 2023

Thermo Fisher Diagnostics ApS has published its annual report for 2022. Gross profit came to DKK 44,114,000, and the net result was DKK 12,562,000.

About Thermo Fisher Diagnostics ApS

Thermo Fisher Diagnostics ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2004. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named PHADIA ApS and SWEDEN DIAGNOSTICS (DENMARK), ApS. The management consists of Pia Finnemann-Andersen. The board consists of Petrus Thomas Adrianus van der Zande (chair), Pia Finnemann-Andersen and Simon Lie. The company is owned by Thermo Fisher Scientific Beteiligungsverwaltungs GmbH. The company has 24 employees (2026). In 2025, the company reported a gross profit of DKK 34,059,000 and a net result of DKK 5,450,000 compared with DKK 6,358,000 the year before. Equity in the 2025 report amounted to DKK 74,863,000.

Source: annual report 2025, Danish Business Authority